Publication:
Response observed during treatment for amyloid a (AA) amyloidosis with eprodisate (NC-503; 1,3-propanedisulfonate) after 2 years in patients with familial mediterranean fever in comparison to patients with rheumatoid arthritis.

Simple item page
dc.contributor.authorsLivneh, A.; Gorevic, P. D.; Direskeneli, H.; Gul, A.; Ozdogan, H.; Hawkins, P. N.; Dember, L. M.; Hachulla, E.; Merlini, G.; Benson, M. D.; Hazenberg, B. P. C.; Garceau, D.; Hauck, W.
dc.date.accessioned2022-03-12T15:59:41Z
dc.date.accessioned2026-01-10T16:51:45Z
dc.date.available2022-03-12T15:59:41Z
dc.date.issued2006
dc.identifier.doidoiWOS:000240877200284
dc.identifier.issn0004-3591
dc.identifier.urihttps://hdl.handle.net/11424/224479
dc.identifier.wosWOS:000240877200284
dc.language.isoeng
dc.publisherWILEY-LISS
dc.relation.ispartofARTHRITIS AND RHEUMATISM
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleResponse observed during treatment for amyloid a (AA) amyloidosis with eprodisate (NC-503; 1,3-propanedisulfonate) after 2 years in patients with familial mediterranean fever in comparison to patients with rheumatoid arthritis.
dc.typeconferenceObject
dspace.entity.typePublication
oaire.citation.endPageS142
oaire.citation.issue9
oaire.citation.startPageS142
oaire.citation.titleARTHRITIS AND RHEUMATISM
oaire.citation.volume54

Files

Collections

Araştırma Çıktıları